Risk factors for liver enzyme elevation with remdesivir use in the treatment of paediatric COVID‐19

Key Points

Key points are not available for this paper at this time.

Abstract

Remdesivir (RDV) causes liver enzyme elevation in adults; however, the frequency of this elevation in children and the associated risk factors are largely unknown. Therefore, we aimed to examine risk factors for liver enzyme elevation in hospitalised paediatric patients who received RDV.

Read Full Paperexternally

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Journals

Journal of Paediatrics and Child Health

Institutions

Kobe Children's Hospital

References and Citations

Add This Paper to Your Research Feed

Any time a new paper drops it will be there.